Vranjkovic et al. [19] reported that targeting β-adrenergic receptors, including ADRB1, might represent a promising pharmacotherapeutic strategy for preventing drug relapse, particularly being induced by stress in cocaine addicts. This evidence concerns the gene ADRB1 and cocaine dependence.